Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Stem Cell and HOT in Type 2 Diabetes
NCT01786707Phase 2Completed
- Start
- Jul 2009
- Primary completion
- Mar 2011
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Autologous Mesenchymal Stem Cells in type 2 diabetes mellitus (T2DM). Started Jul 2009; status: completed.
02
Drugs
Autologous Mesenchymal Stem Cells
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01786707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01786707.